Mouse lacking the expression of interferon regulatory factor 2 (IRF-2)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5675059
SERIAL NO

08117777

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The transcription factors, IRF-1 and IRF-2 are induced by interferons (IFNs) and a variety of other cytokines. IRF-1 functions as an activator whereas IRF-2 represses IRF-1 action by competing for binding to the same cis-elements. Recently, it has been shown that balanced expression between these two factors is critical for maintaining normal restraints on cell growth. Mutant mice deficient for IRF-2 were prepared by homologous recombination. In mutant cells, infection by Newcastle disease virus (NDV) resulted in the induction of type I IFN (IFN-.alpha. and IFN-.beta.) mRNAs, the levels of which were significantly higher than in wild type cells; whereas, such a difference was not found upon induction by poly(I):poly(C). Unlike the IRF-1 deficient mutant mice, the IRF-2 deficient mice of the invention exhibit multiple phenotypes of physical vulnerability, including lethality to lymphocytic choriomeningitis virus (LCMV). Furthermore, in vitro colony formation assays have revealed a remarkable suppression of B cell lymphopoiesis in IRF-2 deficient mice.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONTARIO CANCER INSTITUTE THE500 SHERBOURNE STREET TORONTO M4X 1K9

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mak, Tak W Toronto, CA 30 326
Taniguchi, Tadatsugu Osaka, JP 31 394

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation